(Q36416773)

14 August 2017

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use (English)

1 reference

14 August 2017

1 reference

0 references

1

William H Shrank

1 reference

14 August 2017

8

Jerry Avorn

1 reference

14 August 2017

6

M Alan Brookhart

1 reference

14 August 2017

Margaret Stedman

2

1 reference

14 August 2017

Susan L Ettner

3

1 reference

14 August 2017

Dee DeLapp

4

1 reference

14 August 2017

June Dirstine

5

1 reference

14 August 2017

Michael A Fischer

7

1 reference

14 August 2017

Steven M Asch

9

1 reference

14 August 2017

24 July 2007

1 reference

Journal of General Internal Medicine

14 August 2017

1 reference

14 August 2017

22

1 reference

14 August 2017

9

1 reference

14 August 2017

1298-1304

1 reference

https://scigraph.springernature.com/pub.10.1007/s11606-007-0284-3

14 August 2017

0 references

cites work

Increasing generic drug use in Medicare Part D: the role of government

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Association of income and prescription drug coverage with generic medication use among older adults with hypertension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

The effect of pharmacy benefit design on patient-physician communication about costs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

The effects of prescription drug cost sharing: a review of the evidence.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Do drug samples influence resident prescribing behavior? A randomized trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Medication refill logistics and refill adherence in HIV.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Physician strategies to reduce patients' out-of-pocket prescription costs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Effects of generic-only drug coverage in a Medicare HMO.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Projecting future drug expenditures--2004.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

The effect of incentive-based formularies on prescription-drug utilization and spending

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Effect of tiered prescription copayments on the use of preferred brand medications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Health spending growth up in 1999; faster growth expected in the future

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Pharmacy benefits and the use of drugs by the chronically ill.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Using aggregate geographic data to proxy individual socioeconomic status: does size matter?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2219782

Effect of incentive-based formularies on drug utilization and spending

5 December 2018

1 reference

12 December 2020

Self-reported physician specialties and the primary care content of medical practice: a study of the AMA physician masterfile. American Medical Association

1 reference

12 December 2020

The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions

1 reference

12 December 2020

Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care

1 reference

12 December 2020

10.1007/S11606-007-0284-3

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

1 reference